US to resume J&J COVID vaccinations despite rare clot risk
FILE - In this March 3, 2021, file photo, U.S. Army medic Kristen Rogers, of Waxhaw, N.C., holds a vial of the Johnson & Johnson COVID-19 vaccine in North Miami, Florida. (Marta Lavandier/AP Ffile)
Federal health officials decided that J&J’s one-and-done vaccine is critical to fight the pandemic — and that the small clot risk could be handled with warnings.
Comments have been disabled on this story.